Pharmconsul Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 23.01%
- Profit Growth 5.03%
- Ebitda 10.20%
- Net Worth 62.63%
- Total Assets 25.38%
About Pharmconsul
Pharmconsul Private Limited (PPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2019 (Five years and eight months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Harish Rachamalla and Shailesh Morishetty serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72200TG2019PTC133251
-
Company No.
133251
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jun 2019
-
Date of AGM
21 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pharmconsul?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harish Rachamalla
|
Director | 08-Aug-2022 | Current |
|
Shailesh Morishetty
|
Director | 10-Jun-2019 | Current |
Financial Performance of Pharmconsul.
Pharmconsul Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.01% increase. The company also saw a slight improvement in profitability, with a 5.03% increase in profit. The company's net worth Soared by an impressive increase of 62.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmconsul?
In 2021, Pharmconsul had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmconsul?
Unlock and access historical data on people associated with Pharmconsul, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmconsul, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmconsul's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
